Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial
Table 1
Risk factors of thromboembolism.
Event
TXA ()
Floseal® ()
Placebo ()
value
Age(yr) >70
18/34 (50.0%)
16/34 (47.1%)
17/35 (48.6%)
0.739
BMI (kg/m2) >25
24/34 (70.6%)
26/34 (76.5%)
31/35 (88.6%)
0.177
CAD
10/34 (29.4%)
9/34 (26.5%)
6/35 (17.1%)
0.462
Stroke history
0/0 (0%)
1/34 (2.9%)
0/0 (0%)
0.359
Malignancy history
2/34 (5.9%)
3/34 (8.8%)
7/35 (20.0%)
0.225
History of deep vein thrombosis
0/0 (0%)
0/0 (0%)
0/0 (0%)
—
BMI: body mass index; CAD: coronary artery disease; TXA: tranexamic acid.
